MS

Michael Secora

North America, Utah, United States, Salt Lake City

Description

Michael Secora is the Chief Financial Officer at Recursion Pharmaceuticals.

Investor Profile

Michael Secora has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Michael Secora frequently co-invest with?

Zetta Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
11.2 Capital
North America, California, United States, San Francisco
Co-Investments: 1
EPIC Ventures
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 1
North South Ventures
North America, California, United States, San Francisco
Co-Investments: 1
IV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
DCVC
North America, California, United States, San Francisco
Co-Investments: 1
CB
North America, New York, United States, New York
Co-Investments: 1

Which angels does Michael Secora often collaborate with?

CG
North America, Utah, United States, Salt Lake City
Shared Deals: 1
VC
North America, Colorado, United States, Boulder
Shared Deals: 1
CK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Michael Secora?

Noetik

South San Francisco, California, United States

Noetik is an AI-native biotechnology company.

BiotechnologyLife Science
SeedSep 7, 2023
Amount Raised: $14,000,000